Next Article in Journal
Soluble IL-2R as a Marker of T Cell Activation in Immune-Mediated Diseases: Review and Case-Based Interpretation
Previous Article in Journal
Management of Secondary Immunodeficiency Following T-Cell-Engaging Immunotherapeutic Agents in B-Cell Non-Hodgkin Lymphoma: Implications for Early-Line Treatment Strategies
 
 
Commentary

Article Versions Notes

Lymphatics 2024, 2(4), 260-264; https://doi.org/10.3390/lymphatics2040020
Action Date Notes Link
article xml file uploaded 23 December 2024 16:52 CET Original file -
article xml uploaded. 23 December 2024 16:52 CET Update https://www.mdpi.com/2813-3307/2/4/20/xml
article pdf uploaded. 23 December 2024 16:52 CET Version of Record https://www.mdpi.com/2813-3307/2/4/20/pdf
article html file updated 23 December 2024 16:54 CET Original file https://www.mdpi.com/2813-3307/2/4/20/html
Back to TopTop